| For: | Martín-Rubio P, Espiau-Romera P, Royo-García A, Caja L, Sancho P. Metabolic determinants of stemness in medulloblastoma. World J Stem Cells 2022; 14(8): 587-598 [PMID: 36157911 DOI: 10.4252/wjsc.v14.i8.587] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v14/i8/587.htm |
| Number | Citing Articles |
| 1 |
Shuaishuai Xue, Zhengming Zhan, Yonghua Cai, Wei Chen, Ruizhe Chen, Yangqi Mao, Cheng Xie, Jun Liu, Ziyi Luo, Siyuan Liu, Xian Zhang, Peng Li, Hao Long, Ye Song. PCK2 as a potential therapeutic target for aggressive MYC-amplified non-WNT/non-SHH medulloblastoma based on tumor continuum. Acta Neuropathologica Communications 2026; 14(1) doi: 10.1186/s40478-026-02304-z
|
| 2 |
Manon Penco-Campillo, Gilles Pages, Sonia Martial. Angiogenesis and Lymphangiogenesis in Medulloblastoma Development. Biology 2023; 12(7) doi: 10.3390/biology12071028
|
| 3 |
Amir Modarresi Chahardehi, Aida Naseri, Esfandiar Mali, Leili Ziaei, Fatemeh Moradi, Fatemeh Teimourpour, Leila Tajik, Hossein Motedayyen, Mohammad Saeed Soleimani Meigoli, Reza Nasiri, Reza Arefnezhad, Fatemeh Rezaei-Tazangi. Unveiling the potential benefits of statins in medulloblastoma treatment: A promising therapeutic approach. IBRO Neuroscience Reports 2025; 19 doi: 10.1016/j.ibneur.2025.08.016
|